261 related articles for article (PubMed ID: 20625111)
1. Enalapril in infants with single ventricle: results of a multicenter randomized trial.
Hsu DT; Zak V; Mahony L; Sleeper LA; Atz AM; Levine JC; Barker PC; Ravishankar C; McCrindle BW; Williams RV; Altmann K; Ghanayem NS; Margossian R; Chung WK; Border WL; Pearson GD; Stylianou MP; Mital S;
Circulation; 2010 Jul; 122(4):333-40. PubMed ID: 20625111
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle.
Hsu DT; Mital S; Ravishankar C; Margossian R; Li JS; Sleeper LA; Williams RV; Levine JC; McCrindle BW; Atz AM; Servedio D; Mahony L;
Am Heart J; 2009 Jan; 157(1):37-45. PubMed ID: 19081394
[TBL] [Abstract][Full Text] [Related]
3. Safety of Enalapril in Infants: Data from the Pediatric Heart Network Infant Single Ventricle Trial.
Mathur K; Hsu DT; Lamour JM; Aydin SI
J Pediatr; 2020 Dec; 227():218-223. PubMed ID: 32768465
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle.
Mital S; Chung WK; Colan SD; Sleeper LA; Manlhiot C; Arrington CB; Cnota JF; Graham EM; Mitchell ME; Goldmuntz E; Li JS; Levine JC; Lee TM; Margossian R; Hsu DT;
Circulation; 2011 May; 123(21):2353-62. PubMed ID: 21576655
[TBL] [Abstract][Full Text] [Related]
5. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
[TBL] [Abstract][Full Text] [Related]
6. Translating clinical trials into clinical practice: a survey assessing the potential impact of the Pediatric Heart Network Infant Single Ventricle Trial.
Zak V; Hsu DT; Pemberton VL; Levine JC; Atz AM; Cnota JF; Ravishankar C; Barker P; Lambert LM; McCrindle BW; Frommelt MA; Altmann K; Chen S; Williams RV;
Cardiol Young; 2017 Sep; 27(7):1265-1270. PubMed ID: 28183375
[TBL] [Abstract][Full Text] [Related]
7. Letter by Singh regarding article, "Enalapril in infants with single ventricle: results of a multicenter randomized trial".
Singh TP
Circulation; 2011 Mar; 123(10):e374. PubMed ID: 21403120
[No Abstract] [Full Text] [Related]
8. Comparison of echocardiographic measurements to invasive measurements of diastolic function in infants with single ventricle physiology: a report from the Pediatric Heart Network Infant Single Ventricle Trial.
Goudar SP; Zak V; Atz AM; Altmann K; Colan SD; Falkensammer CB; Friedberg MK; Frommelt M; Hill KD; Hsu DT; Levine JC; Margossian R; Mart CR; Sticka J; Shrader P; Shirali G;
Cardiol Young; 2019 Oct; 29(10):1248-1256. PubMed ID: 31477187
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study.
Solomon SD; Skali H; Bourgoun M; Fang J; Ghali JK; Martelet M; Wojciechowski D; Ansmite B; Skards J; Laks T; Henry D; Packer M; Pfeffer MA;
Am Heart J; 2005 Aug; 150(2):257-62. PubMed ID: 16086927
[TBL] [Abstract][Full Text] [Related]
10. Letter by Burchill et al regarding article, "Enalapril in infants with single ventricle: results of a multicenter randomized trial".
Burchill LJ; Ross HJ; Wald RM
Circulation; 2011 Mar; 123(10):e373. PubMed ID: 21403119
[No Abstract] [Full Text] [Related]
11. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study.
Krum H; Massie B; Abraham WT; Dickstein K; Kober L; McMurray JJ; Desai A; Gimpelewicz C; Kandra A; Reimund B; Rattunde H; Armbrecht J;
Eur J Heart Fail; 2011 Jan; 13(1):107-14. PubMed ID: 21169387
[TBL] [Abstract][Full Text] [Related]
12. Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial.
Desai AS; Solomon S; Claggett B; McMurray JJ; Rouleau J; Swedberg K; Zile M; Lefkowitz M; Shi V; Packer M
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296397
[TBL] [Abstract][Full Text] [Related]
13. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged > or = 65 years with mild to moderate hypertension.
Lacourcière Y
Clin Ther; 2000 Oct; 22(10):1213-24. PubMed ID: 11110232
[TBL] [Abstract][Full Text] [Related]
15. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.
Nissen SE; Tuzcu EM; Libby P; Thompson PD; Ghali M; Garza D; Berman L; Shi H; Buebendorf E; Topol EJ;
JAMA; 2004 Nov; 292(18):2217-25. PubMed ID: 15536108
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
[TBL] [Abstract][Full Text] [Related]
17. Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.
Dittrich S; Graf E; Trollmann R; Neudorf U; Schara U; Heilmann A; von der Hagen M; Stiller B; Kirschner J; Pozza RD; Müller-Felber W; Weiss K; von Au K; Khalil M; Motz R; Korenke C; Lange M; Wilichowski E; Pattathu J; Ebinger F; Wiechmann N; Schröder R;
Orphanet J Rare Dis; 2019 May; 14(1):105. PubMed ID: 31077250
[TBL] [Abstract][Full Text] [Related]
18. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
[TBL] [Abstract][Full Text] [Related]
19. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
20. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
